Search

Search Constraints

You searched for: Author/Creator ,

Search Results

6674. Apgar scores at 10 min and outcomes at 6–7 years following hypoxic-ischaemic encephalopathy. Issue 6 (29th July 2013)

6678. Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial. Issue 23 (6th November 2022)

6679. Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study. Issue 6 (1st April 2019)

6680. Apixaban for treatment of embolic stroke of undetermined source (ATTICUS) randomized trial – update of patient characteristics and study timeline after interim analysis. (14th October 2021)